239
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation

, , &
Pages 855-865 | Received 06 Apr 2011, Accepted 04 Oct 2011, Published online: 11 Nov 2011

References

  • Yuan XY, Liu W, Zhang P, Wang RY, Guo JY. (2010). Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice. Eur J Pharmacol, 629:147–152.
  • Wu G, Li L, Sung GH, Kim TW, Byeon SE, Cho JY, Park CW, Park HJ. (2010). Inhibition of 2,4-Dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of cordyceps bassiana in NC/Nga Mice. J Ethnopharmacol, 134:504–509.
  • Atarashi K, Kabashima K, Akiyama K, Tokura Y. (2008). Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice. Br J Dermatol, 159:306–313.
  • Kim EC, Lee HS, Kim SK, Choi MS, Lee S, Han JB et al. (2008). The bark of Betula platyphylla var. japonica inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol, 116:270–278.
  • Maitraie D, Hung CF, Tu HY, Liou YT, Wei BL, Yang SC et al. (2009). Synthesis, anti-inflammatory, and antioxidant activities of 18β-glycyrrhetinic acid derivatives as chemical mediators and xanthine oxidase inhibitors. Bioorg Med Chem, 17:2785–2792.
  • Armanini D, Karbowiak I, Funder JW. (1983). Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf), 19:609–612.
  • Lu Y, Li J, Wang G. (2008). In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid. Int J Pharm, 356:274–281.
  • Onishi H, Takahashi H, Machida Y. (2005). Preparation and evaluation of glycyrrhetic acid-containing microparticles as an anti-hepatotoxic system. Drug Dev Res, 66:189–199.
  • Edwards CRW, Burt D, McIntyre MA, De Kloet ER, Stewart PM, Brett L, Sutanto WS, Monder C. (1988). Localisation of 11[β]-hydroxysteroid dehydrogenase–tissue specific protector of the mineralocorticoid receptor. The Lancet, 332:986–989.
  • Puglia C, Ostacolo C, Sacchi A, Laneri S, Bonina F. (2006). In vitro and in vivo evaluation of oligoethylene esters as dermal prodrugs of 18β-glycyrrhetic acid. J Pharm Pharmacol, 58:311–319.
  • Puglia C, Rizza L, Drechsler M, Bonina F. (2010). Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: Characterization and in vitro and in vivo evaluation. Drug Deliv, 17:123–129.
  • Cevc G, Blume G. (1992). Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta, 1104:226–232.
  • Cevc G. (1996). Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst, 13:257–388.
  • Jain S, Sapre R, Tiwary AK, Jain NK. (2005). Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation. AAPS PharmSciTech, 6:513–522.
  • Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK. (2006). Elastic liposomes mediated transcutaneous immunization against Hepatitis B. Vaccine, 24:4847–4855.
  • Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: Development, characterization, and performance evaluation. Drug Dev Ind Pharm, 29:1013–1026.
  • Cevc G, Blume G. (2004). Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta, 1663:61–73.
  • Qiu Y, Gao Y, Hu K, Li F. (2008). Enhancement of skin permeation of docetaxel: A novel approach combining microneedle and elastic liposomes. J Control Release, 129:144–150.
  • Frum Y, Khan GM, Sefcik J, Rouse J, Eccleston GM, Meidan VM. (2007). Towards a correlation between drug properties and in vitro transdermal flux variability. Int J Pharm, 336:140–147.
  • Zhao WJ, Wang BJ, Wei CM, Yuan GY, Bu FL, Guo RC. (2008). Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics. J Clin Pharm Ther, 33:289–294.
  • Shin YW, Bae EA, Kim DH. (2006). Inhibitory effect of ginsenoside Rg5 and its metabolite ginsenoside Rh3 in an oxazolone-induced mouse chronic dermatitis model. Arch Pharm Res, 29:685–690.
  • Dubey V, Mishra D, Jain NK. (2007). Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm, 67:398–405.
  • Barry JA, Gawrisch K. (1994). Direct NMR evidence for ethanol binding to the lipid-water interface of phospholipid bilayers. Biochemistry, 33:8082–8088.
  • Lasic DD. (1998). Novel applications of liposomes. Trends Biotechnol, 16:307–321.
  • Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes. Biomaterials, 21:1879–1885.
  • Chen Y, Lu Y, Chen J, Lai J, Sun J, Hu F et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm, 376:153–160.
  • Sato K, Sugibayashi K, Morimoto Y. (1991). Species differences in percutaneous absorption of nicorandil. J Pharm Sci, 80:104–107.
  • Godin B, Touitou E. (2007). Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev, 59:1152–1161.
  • Verma DD, Verma S, Blume G, Fahr A. (2003). Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm, 258:141–151.
  • Kirjavainen M, Urtti A, Jääskeläinen I, Suhonen TM, Paronen P, Valjakka-Koskela R et al. (1996). Interaction of liposomes with human skin in vitro–the influence of lipid composition and structure. Biochim Biophys Acta, 1304:179–189.
  • Sakuma S, Higashi Y, Sato N, Sasakawa T, Sengoku T, Ohkubo Y et al. (2001). Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). Int Immunopharmacol, 1:1219–1226.
  • Simons FE. (1992). The antiallergic effects of antihistamines (H1-receptor antagonists). J Allergy Clin Immunol, 90:705–715.
  • Bielory L. (2004). Complementary and alternative interventions in asthma, allergy, and immunology. Ann Allergy Asthma Immunol, 93:S45–S54.
  • Hisatomi A, Kubota A, Ohashi M, Umeda F, Nawata H, Imamura T et al. (1997). Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome. Fukuoka Igaku Zasshi, 88:11–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.